Preimplantation Genetic Testing (PGT)
Preimplantation Genetic Testing screens embryos for chromosomal abnormalities before transfer during IVF, using advanced NGS technology to support informed embryo selection, reduce miscarriage risk, and improve overall pregnancy outcomes and success.
Clinical Insight
How PGT Works
Preimplantation Genetic Testing (PGT) is an advanced NGS-based test performed on embryo biopsy samples collected during in vitro fertilization. Using Ion Torrent sequencing technology, the assay screens embryos for chromosomal abnormalities before transfer, allowing fertility specialists to identify chromosomally normal embryos with the greatest potential for successful implantation.
By screening embryos prior to transfer, PGT enables more informed embryo selection during the IVF process, helping reduce the risk of failed implantation and early pregnancy loss. This approach supports improved IVF success rates while giving fertility teams and intended parents greater clarity, confidence, and peace of mind throughout each stage of treatment, ultimately guiding toward healthier pregnancy outcomes and long-term reproductive success for many hopeful families.
Clinical Applications
PGT is used within IVF and Assisted Reproductive Technology, screening embryo biopsy samples to guide embryo selection before transfer.
Clinical Applications
The PGT-A panel evaluates embryos for chromosomal aneuploidies, helping identify embryos with a normal chromosome count for clinical transfer.
Testing Benefits
Precision Testing for Better Outcomes
Improved Embryo Selection
PGT-A helps identify chromosomally normal embryos, allowing fertility specialists to make more informed, evidence-based decisions during embryo selection, improving overall treatment outcomes.
Reduced Miscarriage Risk
By screening out chromosomally abnormal embryos before transfer, PGT lowers the risk of miscarriage linked to underlying chromosomal abnormalities in early pregnancy.
Better IVF Success Rates
Selecting embryos with confirmed normal chromosome status contributes to higher implantation rates and improved overall success across IVF treatment cycles for patients.
Minimal Embryo Impact
PGT uses a small embryo biopsy sample, allowing detailed chromosomal screening to be performed with minimal disruption to the embryo's ongoing development.
Advanced NGS Precision
Built on Ion Torrent next-generation sequencing, PGT delivers precise, reliable chromosomal analysis, supporting confident, data-driven decision-making throughout the entire IVF treatment process.
Informed Clinical Decisions
Pre-transfer screening gives fertility teams and intended parents clearer insight into embryo health, enabling more confident, personalized treatment planning at every step.
Schedule Your Test
Our team supports fertility clinics and IVF centers with accurate, scalable embryo screening solutions nationwide today.
